Viracta Therapeutics
(NASDAQ:VIRX)
$3.55
0.21[6.29%]
At close: Jun 29
$3.62
0.0700[1.97%]
After Hours: 7:21PM EDT
Day High/Low3.29 - 3.61
52 Week High/Low1.82 - 12.75
Open / Close3.33 / 3.55
Float / Outstanding20.4M / 37.5M
Vol / Avg.194.8K / 321.5K
Mkt Cap133.1M
P/E2.49
50d Avg. Price2.48
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float20.4M

Viracta Therapeutics (NASDAQ:VIRX), Quotes and News Summary

Viracta Therapeutics (NASDAQ: VIRX)

Day High/Low3.29 - 3.61
52 Week High/Low1.82 - 12.75
Open / Close3.33 / 3.55
Float / Outstanding20.4M / 37.5M
Vol / Avg.194.8K / 321.5K
Mkt Cap133.1M
P/E2.49
50d Avg. Price2.48
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float20.4M
Benzinga - Jun 8, 2022, 4:08AM
Sector: Health Care.Industry: Biotechnology
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.310-0.280 0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Viracta Therapeutics Questions & Answers

Q
How do I buy Viracta Therapeutics (VIRX) stock?
A

You can purchase shares of Viracta Therapeutics (NASDAQ: VIRX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Viracta Therapeutics's (VIRX) competitors?
Q
What is the target price for Viracta Therapeutics (VIRX) stock?
A

The latest price target for Viracta Therapeutics (NASDAQ: VIRX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 35.00 expecting VIRX to rise to within 12 months (a possible 885.92% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Viracta Therapeutics (VIRX)?
A

The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $3.55 last updated June 29, 2022, 8:00 PM UTC.

Q
Does Viracta Therapeutics (VIRX) pay a dividend?
A

There are no upcoming dividends for Viracta Therapeutics.

Q
When is Viracta Therapeutics (NASDAQ:VIRX) reporting earnings?
A

Viracta Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Viracta Therapeutics (VIRX) going to split?
A

There is no upcoming split for Viracta Therapeutics.

Q
What sector and industry does Viracta Therapeutics (VIRX) operate in?
A

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.